Dr. Akishi Onishi, Head of R&D at VCGT Inc., visited Yonehara Lab at NIG and had a biological symposium, “From Research to Reality: A Startup's Approach to Gene-Targeted Therapeutics for Inherited Retinal Diseases”.

Dr. Akishi Onishi, Head of R&D at VCGT Inc., visited Yonehara Lab at NIG and had a biological symposium, “From Research to Reality: A Startup's Approach to Gene-Targeted Therapeutics for Inherited Retinal Diseases”.